News

U.S. authorizes emergency use of an experimental Eli Lilly antibody treatment to fight mild, moderate COVID-19 cases.

Posted November 09, 2020 6:00 am

The Associated Press

WASHINGTON (AP) - U.S. authorizes emergency use of an experimental Eli Lilly antibody treatment to fight mild, moderate COVID-19 cases.

Article Categories
Content Providers Nation and World News